Odyssey Health, Inc. - 28 Dec 2023 Form 3 Insider Report for ORAGENICS INC (OGEN)

Role
10%+ Owner
Signature
/s/ Christine M Farrell, CFO
Issuer symbol
OGEN
Transactions as of
28 Dec 2023
Net transactions value
$0
Form type
3
Filing time
16 Jun 2025, 17:54:50 UTC
Next filing
16 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Odyssey Health, Inc. 10%+ Owner 2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS /s/ Christine M Farrell, CFO 16 Jun 2025 0001626644

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OGEN Series F Preferred Stock 249,623 28 Dec 2023 Direct F1, F3
holding OGEN Common Stock 17,044 28 Dec 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired in Asset Sale on December 28, 2023
F2 Converted on 1:1 basis of Series F Preferred Stock into 19.9% of then outstanding shares of OGEN common stock on December 28, 2023
F3 Shares reflect the 1:30 reverse stock split on June 3, 2025